Petition to Pfizer
Mr Barry Smith, CEO
PFIZER South Africa
PO Box 783720, Sandton
Fax: 011 884 8409
As you know, HIV/AIDS is a major problem in our
country and in Southern Africa. Your company sells the
drug Diflucan (Fluconazole) a life-saving drug
that also improves the quality of life for people with
AIDS. This drug is used to treat cryptoccal meningitis
and systemic thrush. People with AIDS die if they cannot
get access to it.
Diflucan sells at R150.00 for one 200mg capsule in the
private sector and the public sector buys it at R58.00
from your company.
Many people cannot afford to buy the drug in the
private sector. Some public sector hospitals do not
provide it any longer because the system is over-burdened
and cannot afford the price your company charges.
We have learnt that in India where Diflucan is not
patented, a generic version sells at R7.00 per 200mg
capsule and in Thailand for less than R3.00 per 200mg
We urge you to decrease your price to less than R3.00
per 200mg capsule as requested by the Treatment Action
Campaign. This will save many lives. A reduction such as
this will show people that Pfizer is prepared to consider
life before excessive profit.